





































Beyond binary retention in HIV care: predictors of the
dynamic processes of patient engagement,
disengagement, and re-entry into care in a
US clinical cohort
Hana Leea, Xiaotian K. Wua, Becky L. Genbergb, Michael J. Mugaveroc,
Stephen R. Coled, Bryan Laub, Joseph W. Hogana, For the
Centers for AIDS Research Network of Integrated
Clinical Systems (CNICS) Investigators
Objectives: Studies examining engagement in HIV care often capture cross-sectional
patient status to estimate retention and identify predictors of attrition, which ignore
longitudinal patient care-seeking behaviors. We describe the cyclical nature of (dis)-
engagement and re-entry into HIV care using the state transition framework.
Design: We represent the dynamic patterns of patient care-retention using five states:
engaged in care, missed one, two, three, or more expected visits, and deceased. Then
we describe various care-seeking behaviors in terms of transitioning from one state to
another (e.g. from disengaged to engaged). This analysis includes 31 009 patients
enrolled in the Center for AIDS Research Network of Integrated Systems (CNICS) in
the United States from 1996 to 2014.
Method: Multistate models for longitudinal data were used to identify barriers to
retention and subgroups at higher risk of falling out of care.
Results: The initial 2 years following primary engagement in care were a crucial time
for improving retention. Patients who had not initiated antiretroviral therapy, with lower
CD4þ cell counts, higher viral load, or not having an AIDS-defining illness were less
likely to be retained in care.
Conclusion: Beyond the individual patient characteristics typically used to character-
ize retention in HIV care, we identified specific periods of time and points in the
care continuum associated with elevated risk of transitioning out of care. Our
findings can contribute to evidence-based recommendations to enhance long-term
retention in CNICS. This approach can also be applied to other cohort data to identify
retention strategies tailored to each population.
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Introduction
The HIV care cascade (also known as the HIV care
continuum) describes milestones in HIV care and is a
useful model to monitor progress and identify needs for
people living with HIV (PLWH) [1–3]. In most
formulations, the model includes: identification of new
cases, linkage to care, initiation of and adherence to
antiretroviral therapy (ART) through retention in care,
and sustained viral load suppression. The conceptual
model provides a useful framework for evaluating the
effectiveness of HIV care and developing strategies to
improve health outcomes for PLWH, particularly by
identifying factors associated with missing key milestones.
For example, a recent Centers for Disease Control
and Prevention report demonstrated that approximately
86% PLWH in the United States were aware of their
HIV status, about 40% were engaged in care, 37%
were prescribed ART, and 30% had undetectable viral
load [3]. From this summary, we can see that the largest
loss in the continuum occurred during engagement
in care.
Approaches examining the care cascade in this manner fall
short in that they capture cross-sectional snapshots of
binary patient status (e.g. retained in care: yes/no),
aggregated within predefined time periods such as 6 or 12
months, to examine retention rates, and identify
predictors of attrition in short-term periods [4–10].
Some studies acknowledge that longitudinal patient
health-seeking behaviors are more complex than what
is considered using traditional approaches, and thus
should incorporate more dynamic processes of patient
engagement, disengagement, and re-entry into care [11–
14]. In the era of ‘Big Data,’ clinical cohort data consisting
of rich resources from electronic medical records (EMRs)
provide new opportunities to conduct comprehensive
analyses of the HIV care cascade. Whereas EMR and
cohort studies usually do not contain information related
to linkage to care, they do enable the examination of
factors associated with movements in and out of care. Yet,
EMR data have not been fully used to study the dynamics
of care retention partly due to a lack of coherent statistical
methods that can handle longitudinal patient-level
behaviors.
Recently, multistate modeling approaches have become
prominent in characterizing longitudinal patient dynam-
ics along the phases in the HIV care cascade using cohort
data [13,15–17]. In the current analysis, we use the state
transition framework developed by Lee et al. to describe
the longitudinal process of engagement and retention in
HIV care. We use data from the Center for AIDS
Research (CFAR) Network of Integrated Clinical
Systems (CNICS) – one of the most comprehensive
multisite HIV clinical databases in the United States – to




The CNICS is an integrated clinical database composed
of EMR-based data from eight contributing CFAR sites:
University of Alabama at Birmingham (UAB), Case
Western Reserve University, University of California San
Francisco, the University of Washington, the University
of California San Diego, Fenway Health/Harvard
University, University of North Carolina Chapel Hill,
and Johns Hopkins University. Details can be found
elsewhere [18]. PLWH become known to CNICS upon
entry at CNICS-affiliated clinics to receive any HIV
medical care or HIV testing. However, the CNICS
cohort only includes patients with at least two primary
care visits within 12 months since their initial linkage to
CNICS care. As of 31 December 2015, CNICS included
data on 31 852 patients in HIV care including informa-
tion on: demographics, HIV comorbidities, laboratory
tests including CD4þ cell count and HIV-RNA,
medications including ART, healthcare utilization,
vital status, patient-reported outcomes (PROs), ART
resistance, and biologic specimens. Date of death was
confirmed using the national death index (NDI) and
social security death index data (SSDI).
We excluded from this analysis patients with first care
visits before 1996, when ART became widely available, in
order to examine the effect of initiating ART on care
retention in the modern ARTera. We also excluded those
who entered the cohort within 200 days of the study end
date – 31 December 2014. Hence this analysis included
follow-up data from 31 009 patients who enrolled in HIV
care in a CNICS-affiliated site from January 1996 through
December 2014.
Model formulation and state definition
To ascertain patient-level engagement and retention
status, individual follow-up times were partitioned into
roughly 6-month intervals reflecting the CNICS viral
load monitoring guidelines (viral load monitoring twice a
year at minimum), as viral load is often used as a proxy
measure for having had a care visit. We used a 200-day
interval to allow scheduling variations. Because of the
inclusion criteria for CNICS requiring patients to have
had at least two clinical visits within 12 months of
enrollment in care, we defined time zero in this analysis as
the date of the second visit, referred to here as baseline, to
avoid artificially inflating engagement rates within the
first 200-day time interval.
We defined longitudinal patterns of patient engagement
in HIV care using five mutually exclusive states: Engaged
in care (state 1), disengaged from care for one period (state
2), for two periods (state 3), for three or more periods
(state 4), and deceased (state 5). The model captured
patient-level transitions from and within states such as
transitioning within engaged (retention), from engaged to
disengaged, within disengaged, from disengaged to
engaged (re-entry into care), and ultimately death
(mortality). A graphical representation of the model is
shown in Fig. 1.
We assigned state membership at each interval end-point
using the following algorithm: the individual patient’s
state was defined as ‘engaged in care’ if there was any
record of a clinical encounter within the given 200-day
time interval. If there was no clinic visit, the individual
was disengaged from care unless he/she died within that
time interval based on the date of death. Death was
defined as an absorbing state, implying that no further
transitions were allowed. All patients were considered
engaged at baseline by the operational definition of the
CNICS. Accordingly, transitions from states 2, 3, and 4
were examined starting 200, 400, and 600 days after
baseline, respectively.
Statistical analysis
Various transitions can be captured using conditional
probabilities Pt jk ¼ prðSt ¼ kjSt1 ¼ jÞ, where t
denotes time at each interval end point, k and j denote
states, and St denotes state at time t. For example, Pt11 ¼
prðSt ¼ 1jSt1 ¼ 1Þ represents the probability of reten-
tion at time t as it captures transitioning within the
engaged state. Using these probabilities, first we estimated
time-aggregated rates for each transition such as
retention, engagement to disengagement, re-entry into
care, and so on. We created plots of estimated transition
probabilities over time to provide a visual representation
of temporal variations in transition dynamics.
State membership at each time t follows a multinomial
distribution. Therefore, the discrete time multistate-
model, formulated in terms of multinomial regression for
repeated measures [15], was used to estimate the effects of
covariates associated with state transitions while control-
ling for the effects of site, duration of follow-up, and
calendar time, along with within-subject correlations.




¼ at jk þ xtb jk
where atjk is a time-specific intercept, xt is vector of
covariates, and bjk represents relative risk ratios (RRRs)
which represent the effect of covariates on transitions
from state j to k relative to the transition from state j to a
reference state. Duration of follow-up and calendar-year
were fit using splines. We set transition to engagement in
care as the reference. We used 1000 bootstrap samples for
longitudinal data to estimate standard errors and confi-
dence intervals (CIs) for covariate effects.
We examined the effect of patient-level characteristics
that are known to be associated with retention in HIV
care from the published literature [6,9,12,19–26], while
controlling for site and temporal trends. Covariates
included in multistate models were as follows: CD4þ cell
count (<250, 250–500, >500 cells/ml) [19,20,26,27],
log10 viral load [9,21], ART initiation (yes vs. no) [25,26],
ART initiation by calendar period associated with
changes in WHO guidelines for ART eligibility
(1996–2002, 2001–2003–2006, 2007–2010, and
2011þ) [28–30], diagnosis of AIDS-defining illness
(yes vs. no) [19,22], race (White, African American,
others) [4,6,20,22,26], Hispanic ethnicity (yes vs. no)
[4,6,20,22], age (40 vs. >40 years) [6,20,22,24,26],
HIV risk factors by sex [(MSM) who are noninjection
drug users (non-IDUs), MSM IDU, male heterosexual
non-IDU, male heterosexual IDU, female heterosexual
non-IDU, female heterosexual IDU, others)] [4,6,22],
site (UAB as reference), duration of follow-up, and
calendar-year. We considered an interaction between
ART initiation and calendar periods reflecting changes in
ART guidelines to examine the impact of changes in
patient eligibility for ART initiation on care retention.
Fig. 1. Graphical representation of retention aspects of care in the spanning of the HIV care continuum.  Circles represent
operational states that define the care retention. ‘Engaged’ represents engaged in care state. ‘Disen 1, 2, and 3þ’ represents
disengaged for 1 interval (200 days; missed 1 expected clinical visit), 2 consecutive intervals (missed two visits), and 3 or more
intervals (missed 3 or more visits), respectively. Arrows represent all possible one-step transitions within and between states and
their practical meanings.
We also considered combinations of sex (at present) and
HIV risk factors as a single covariate consisting of mutually
exclusive categories. Information regarding injection drug
use is coupled with sexual orientation in CNICS. Missing
was considered as a valid category for each covariate and
interpreted as ‘information never measured from clinic or
never provided from the patient.’ Covariates were time-
fixed except for CD4þ cell count, viral load, ART, AIDS,
duration of follow-up, and calendar-year.
Throughout, we refer to an observed association as
‘statistically significant’ (at the 5% significance level) if the
95% CI for RRR excludes 1.
Results
Sample characteristics
Patients in the study sample were 81% male, 11% White,
and 39% African Americans (Table 1). HIV acquisition
risk factors were mostly MSM (51%) or heterosexual
behaviors (30%). Median age at study entry was 39 years
[interquartile range (IQR) 32–46]. Median CD4þ cell
counts and log10 viral load at study entry were 348 (IQR
155–556), and 4.46 (IQR 3.66–5.06), respectively.
Summary of transition rates and temporal trends
We calculated time-averaged, overall state transition
probabilities (Table S1 in supplemental data, http://
links.lww.com/QAD/B317). Among patients engaged in
CNICS care in a given 200-day interval, the rate of
retention was 0.86, whereas disengagement was 0.13,
and death was 0.01. Transition from disengaged states
indicated the cyclic nature of engagement in care: among
patients disengaged for one, two, and at least three
intervals, 34, 14, and 3% returned to care, respectively.
The per-interval mortality rate (aggregating values in the
last column of Table S1 in supplemental data, http://
links.lww.com/QAD/B317) was about 0.05.
Figure 2 shows temporal trends in transition probabilities
from either engaged in care or disengaged from care
Table 1. Characteristics of 31 009 HIV-infected patients who were engaged in CNICS-affiliated HIV care between 1 January 1996 and 31
December 2014, at enrollment.
Characteristic Number (%) Median (IQR) % Missing









Initiated ART 28303 (91.3%) 8.7
AIDS-defining illness 10550 (34%) 18.6
Black race 11961 (38.6%) 3.3
Hispanic ethnicity 3442 (11.1%) 8.1
Age 39 (32, 46)
Male sex 25103 (81%) 0
Sex and HIV risk factors 3
Male MSM non-IDU 14226 (45.9%)
Male MSM IDU 1623 (5.2%)
Male heterosexual non-IDU 3405 (11%)
Male heterosexual IDU 1014 (3.3%)
Female heterosexual non-IDU 4100 (13.2%)
















ART, aniretroviral therapy; CNICS, Center for AIDS Research Network of Integrated Systems; CWRU, Case Western Reserve University; IDU,
injection drug user; IQR, interqartile range; JHU, Johns Hopkins University; UAB, University of Alabama at Birmingham; UCSD, University of
California San Diego; UNC, University of North Carolina at Chapel Hill; UW, University of Washington.
through 15 years of follow-up. Fig. 2a indicates a sharp
decrease in the probability of retention (solid line) around
the first year since baseline. Patients who were disengaged
within the first year were at additional high risk of
remaining disengaged in the following year, according to
a sharp increase in the probability of continued
disengagement (dashed line) between year 1 and 2
(Fig. 2b). In addition, Figs. 2c and d imply that patients
disengaged for two or more intervals were much more
likely to remain disengaged from care (dashed lines)
compared to returning to care (solid lines). Mortality rates
were relatively stable among care-engaged and disengaged
patients and were constantly less than 0.02 per-interval
time. In sum, Fig. 2 demonstrates that the most critical
period to retain CNICS patients in care are the first
2 years following enrollment. Patients with longer
disengagement were at much higher risk of continued
disengagement (conversely, much less likely to come back
for care) than those having shorter disengagement for
most of the follow-up period (data not shown). We did
not observe a meaningful difference in mortality between
care-engaged and disengaged patients.
Effect of clinical characteristics on
retention-related behaviors
Overall, clinical characteristics were significantly associ-
ated with transitions among patients who were engaged in
CNICS care (Table 2); First, risk of transitioning from
engaged to disengaged relative to remaining engaged in
care among patients with CD4þ cell counts 250–500
cells/ml, compared to those with CD4þ cell counts below
250 cells/ml, was 0.87 (95% CI 0.83, 0.90). Similarly,
care-engaged patients with CD4þ cell count at least 500
cells/ml were significantly less likely to disengage from
care compared to those with CD4þ cell count below 250
cells/ml (RRR 0.79, 95% CI 0.76, 0.83). Therefore,
patients with lower CD4þ cell counts (<250 cells/ml)
were significantly more likely to disengage from care
rather than remain retained in care compared to those
with higher CD4þ cell counts. Among care-engaged
patients with viral load measurements, those with higher
viral load were more likely to disengage from care (RRR
1.26, 95% CI 1.24, 1.27). Care-engaged patients who
initiated ART were less likely to disengage from care
(RRR 0.80, 95% CI 0.75, 0.85). Among patients who
initiated ART, those who initiated after 2006 were less
likely to disengage from care compared to those who
initiated in 1996–2002. Patients with CD4þ cell count
<250 cells/ml, higher viral load, or no ART were also
more likely to die, despite their prior engagement with
care, compared to patients with CD4þ cell count 250
cells/ml, lower viral load, or ART. Among patients who
initiated ART, mortality after engagement in care was













































































































Fig. 2. Temporal trends in state transition probabilities among care-engaged and care-disengaged patients over 15 years of
follow-up period, presented in logit scale to amplify probabilities close to zero.
during 2003–2010 compared to those initiated in 1996–
2002. However, no difference in mortality was found
between patients who initiated in recent years (after 2010)
compared to 1996–2002. Care-engaged patients with
AIDS were less likely to disengage from care, but much
more likely to die than patients without AIDS.
Clinical characteristics were, in general, significantly
associated with transitions among patients who were
disengaged from care as well (Table 3); among patients
disengaged from care, those with higher CD4þ cell count
(250 cells/ml) were less likely to die compared to those
with lower CD4þ cell counts. Among patients with
viral load measured, higher viral load was consistently
associated with continued disengagement and death.
Initiating ART was negatively associated with continued
disengagement and death among disengaged patients in
most situations. Among patients who initiated ART,
continued disengagement from care was significantly
lower among those who initiated ART after 2006
compared to those who initiated in 1996–2002. In
addition, mortality following long-term disengagement
from care (3 intervals) was significantly lower among
those who initiated ART after 2010 compared to those
who initiated in 1996–2002. Patients with AIDS were
consistently less likely to continue to be disengaged, but
more likely to die in most cases.
Racial/ethnicity disparity in retention
Among care-engaged patients, we observed no differ-
ences in disengagement from care by race. However,
African American patients were less likely to die
following engagement, compared to White patients
(RRR 0.90, 95% CI 0.82, 0.98). Non-Hispanic patients
were more likely to disengage from care and die following
engagement compared to patients reporting Hispanic
ethnicity.
We observed a significant difference in the probability of
continued disengagement by race. In general, African
American patients were less likely to continue to be
disengaged compared to White patients in CNICS.
Effect of age and HIV risk factors on retention
Among care-engaged patients, age and sex-HIV risk
factors were significantly associated with transitions out of
care: older patients (age 40 years) were less likely to
disengage from care compared to younger patients, but
Table 2. Relative risk ratios (RRRs) and 95% bootstrapped confidence intervals for effect of covariates on transitions from engaged in care to
disengaged for 1 interval or death, relative to remaining engaged in care.
Prior state Engaged
Current state Disengaged Death
CD4þ cell counts (Ref: <250 cells/ml)
250–500 cells/ml 0.87 (0.83, 0.90) 0.28 (0.25, 0.30)
>500 cells/ml 0.79 (0.76, 0.83) 0.17 (0.15, 0.19)
Never measured 4.67 (4.27, 5.16) 2.09 (1.66, 2.66)
Viral load (VL) measured 0.31 (0.29, 0.33) 0.28 (0.23, 0.34)
log10 VL among measured 1.26 (1.24, 1.27) 1.27 (1.23, 1.30)
Initiated ART 0.80 (0.75, 0.85) 0.60 (0.53, 0.69)
Year initiated ART (Ref: 1996–200)
2003–2006 1.03 (0.98, 1.09) 1.14 (1.01, 1.29)
2007–2010 0.91 (0.85, 0.98) 1.24 (1.05, 1.49)
2011þ 0.79 (0.72, 0.87) 1.25 (0.95, 1.64)
Missing ART information 2.11 (1.95, 2.31) 2.75 (2.30, 3.35)
AIDS-defining illness 0.67 (0.65, 0.70) 2.69 (2.50, 2.92)
Race (Ref: Caucasian)
African American 1.02 (0.98, 1.06) 0.90 (0.82, 0.98)
Others 1.03 (0.97, 1.01) 0.86 (0.71, 1.03)
Missing 1.21 (1.09, 1.35) 1.40 (1.04, 1.84)
Hispanic ethnicity 0.79 (0.74, 0.84) 0.64 (0.54, 0.75)
Missing ethnicity 2.06 (1.83, 2.30) 2.08 (1.62, 2.65)
Age >40 years 0.72 (0.70, 0.74) 1.70 (1.57, 1.85)
Sex and HIV risk factorsa (Ref: MSM NIDU)
MSM IDU 1.02 (0.95, 1.09) 1.43 (1.21, 1.69)
Male hetero NIDU 1.10 (1.04, 1.15) 1.41 (1.24, 1.61)
Male hetero IDU 1.14 (1.05, 1.25) 1.91 (1.62, 2.24)
Female hetero NIDU 0.99 (0.95, 1.04) 1.14 (0.99, 1.29)
Female hetero IDU 0.94 (0.86, 1.03) 1.62 (1.32, 1.92)
Others 1.10 (1.05, 1.15) 1.58 (1.42, 1.75)
Missing 1.28 (1.16, 1.40) 2.08 (1.69, 2.54)
Factors that their 95% CI excludes 1 are highlighted in bold. All effects are adjusted by site, duration of follow-up, and calendar time (see
Supplemental data). Hetero, heterosexual contacts; IDU, injection drug user; NIDU, none injection drug user.
aSex and HIV risk factors are combined. There is no main effect of sex as sex spans multiple risk factor categories. Also, injection drug use
information is coupled with sexual orientation information to determine HIV risk factors in CNICS.
For time-varying covariates (CD4þ, VL, ART, and AIDS), the most recently observed values obtained at last time engaged in care were used.
had higher mortality rates. There was no effect of
injection drug use on becoming disengaged among
MSM, but IDU MSM had higher mortality than non-
IDU MSM. Among male non-IDU, those identifying as
heterosexual were more likely to disengage from care or
die compared to MSM. Male heterosexual IDU were
more likely to disengage or die compared to non-IDU
MSM. No significant differences between non-IDU
MSM and non-IDU female heterosexuals were observed.
However, female heterosexual IDUs were in general
more likely to die compared to non-IDU MSM.
Discussion
The article presents a longitudinal examination of
retention dynamics in the HIV care cascade. To our
knowledge, this is among the first studies to make use of
almost 20 years of cohort data from the modern ARTera
to examine temporal trends and factors associated with
various transitions from care.
Our analysis shows the value of looking at temporal
variations and some key factors to form a targeted policy
or tailored monitoring/outreach plan to increase reten-
tion in HIV care. For example, our findings indicated that
preventing early disengagement within the first 2 years
following enrollment might be critical to prevent longer-
term disengagement. This can inform development and
calibration of existing retention-related efforts in CNICS,
which are similar to approaches described in [31]. More
aggressive efforts early on to retain patients in care, such as
developing a risk score that identifies patients who are at
high risk of disengagement from care, and more intensive
outreach for those who disengaged to re-engage them
within the first 2 years after enrollment may enhance
long-term retention rates in the CNICS cohort.
In addition to temporal trends, we identified that lower
CD4þ cell counts, higher viral load, not initiating ART,
and having an AIDS-defining illness was consistently
associated with various care-disengagement outcomes in
CNICS. Previous studies with shorter follow-up (1
year) demonstrated that those with higher CD4þ cell
counts were less likely to be retained in care or more likely
to miss scheduled appointments [19,20,26]. The discrep-
ancy might be due to differing cohort eligibility criteria
and durations of follow-up. Also, it is possible that our
results show the consequences of better retention as they
indicate only the associational relationship. Nonetheless,
increased attention to monitoring the aforementioned
subgroups of patients may maximize CNICS care efforts.
From the effect of changes in ARTeligibility guidelines,
Table 3. Relative risk ratios (RRRs) and 95% bootstrapped confidence intervals for effect of covariates on transitions from disengaged states to
continued disengagement or death, relative to remaining engaged in care.
Prior state Disengaged 1 Disengaged 2 Disengaged 3þ
Current state Disengaged 2 Death Disengaged 3þ Death Disengaged 3þ Death
CD4þ cell counts (Ref: <250 cells/ml)
250–500 cells/ml 0.97 (0.91, 1.05) 0.38 (0.30, 0.48) 1.18 (1.05, 1.33) 0.51 (0.35, 0.74) 1.19 (1.08, 1.32) 0.63 (0.53, 0.75)
>500 cells/ml 0.83 (0.77, 0.89) 0.18 (0.13, 0.24) 1.15 (1.01, 1.30) 0.26 (0.16, 0.40) 1.10 (0.99, 1.23) 0.49 (0.40, 0.59)
Never measured 5.39 (4.35, 6.87) 2.68 (1.61, 4.56) 3.22 (2.32, 4.78) 1.26 (0.61, 2.60) 2.94 (2.29, 3.94) 1.50 (1.06, 2.14)
Viral load (VL) measured 0.59 (0.51, 0.67) 0.25 (0.16, 0.38) 0.53 (0.40, 0.69) 0.11 (0.05, 0.23) 0.28 (0.22, 0.35) 0.14 (0.10, 0.19)
log10 VL among measured 1.04 (1.02, 1.06) 1.27 (1.18, 1.35) 0.96 (0.92, 0.99) 1.24 (1.11, 1.41) 1.06 (1.03, 1.10) 1.26 (1.19, 1.33)
Initiated ART 1.04 (0.92, 1.17) 0.70 (0.49, 0.99) 1.14 (0.95, 1.35) 0.78 (0.49, 1.35) 1.19 (1.02, 1.40) 1.11 (0.87, 1.45)
Year initiated ART (Ref: 1996–2002)
2003–2006 0.98 (0.89, 1.08) 1.40 (1.03, 1.94) 0.88 (0.75, 1.05) 0.85 (0.52, 1.27) 0.59 (0.52, 0.68) 0.72 (0.56, 0.90)
2007–2010 0.82 (0.73, 0.93) 1.19 (0.76, 1.90) 0.67 (0.54, 0.86) 0.95 (0.48, 1.66) 0.24 (0.20, 0.29) 0.35 (0.22, 0.53)
2011þ 0.62 (0.52, 0.74) 0.60 (0.25, 1.36) 0.36 (0.26, 0.50) 0.67 (0.11, 1.92) 0.05 (0.04, 0.07) 0.17 (0.05, 0.34)
Missing ART information 2.55 (2.18, 3.07) 2.72 (1.62, 4.36) 2.48 (1.93, 3.41) 2.32 (1.25, 4.55) 3.03 (2.39, 3.90) 2.92 (2.07, 4.16)
AIDS-defining illness 0.79 (0.73, 0.85) 2.54 (2.03, 3.13) 0.72 (0.64, 0.81) 1.65 (1.16, 2.34) 0.47 (0.41, 0.52) 0.72 (0.59, 0.88)
Race (Ref: Caucasian)
African American 0.84 (0.79, 0.90) 0.71 (0.57, 0.90) 0.77 (0.69, 0.86) 0.92 (0.67, 1.31) 0.72 (0.65, 0.78) 0.94 (0.79, 1.10)
Others 0.96 (0.87, 1.08) 0.99 (0.61, 1.50) 0.89 (0.74, 1.09) 0.65 (0.24, 1.22) 1.08 (0.93, 1.26) 0.90 (0.59, 1.26)
Missing 1.34 (1.11, 1.66) 1.46 (0.48, 3.14) 1.38 (1.00, 2.01) 1.25 (0.22, 3.05) 1.67 (1.26, 2.25) 1.01 (0.50, 1.80)
Hispanic ethnicity 0.96 (0.87, 1.07) 0.50 (0.28, 0.79) 0.90 (0.75, 1.08) 0.52 (0.25, 0.91) 0.98 (0.84, 1.15) 0.71 (0.49, 0.98)
Missing ethnicity 1.43 (1.20, 1.73) 2.32 (1.20, 3.98) 2.70 (2.03, 3.77) 4.29 (1.74, 8.66) 2.13 (1.74, 2.68) 3.15 (2.14, 4.48)
Age >40 years 0.98 (0.92, 1.03) 2.04 (1.66, 2.53) 1.04 (0.94, 1.14) 1.93 (1.42, 2.71) 1.25 (1.16, 1.36) 2.27 (1.92, 2.71)
Sex and HIV risk factors (Ref: MSM NIDU)
MSM IDU 1.02 (0.90, 1.16) 1.62 (1.05, 2.41) 0.83 (0.69, 1.01) 1.24 (0.65, 2.23) 0.77 (0.65, 0.91) 1.38 (1.01, 1.92)
Male hetero NIDU 0.89 (0.80, 0.98) 1.12 (0.80, 1.52) 0.75 (0.64, 0.86) 1.26 (0.77, 1.97) 0.82 (0.72, 0.95) 0.94 (0.72, 1.21)
Male hetero IDU 1.12 (0.96, 1.28) 1.97 (1.27, 2.99) 0.75 (0.59, 0.97) 1.77 (0.87, 3.31) 0.63 (0.51, 0.77) 1.17 (0.83, 1.63)
Female hetero NIDU 1.01 (0.92, 1.10) 1.07 (0.77, 1.46) 0.86 (0.74, 0.99) 1.43 (0.89, 2.33) 0.81 (0.73, 0.92) 0.73 (0.56, 0.94)
Female hetero IDU 0.89 (0.76, 1.04) 1.80 (1.10, 2.81) 1.03 (0.78, 1.41) 1.97 (0.78, 3.97) 0.69 (0.55, 0.87) 1.71 (1.18, 2.50)
Others 1.07 (0.99, 1.16) 1.49 (1.13, 1.97) 0.90 (0.79, 1.02) 1.37 (0.92, 2.10) 0.78 (0.70, 0.87) 1.38 (1.13, 1.69)
Missing 1.25 (1.07, 1.48) 1.52 (0.81, 2.53) 1.21 (0.88, 1.72) 3.89 (1.98, 7.66) 1.76 (1.36, 2.32) 2.93 (2.06, 4.37)
Factors that their 95% CI excludes 1 are highlighted in bold. All effects are adjusted by site, duration of follow-up, and calendar time (see
Supplemental data).
we observed that patients who initiated ART in recent
years (2010 or later where the test and treat strategy
became prominent) showed lower rates of disengage-
ment from care. Our results therefore further support
continued scale-up and implementation of the test and
treat strategy, not only as part of HIV and AIDS
prevention, but also as a strategy to improve care
retention and reduce mortality among PLWH, as taking
ART and the expansion of ARTeligibility criteria were
shown to be associated with better retention and
lower mortality.
We also found reverse relationships in retention compared
to findings from other studies [4,23,26]. We observed that
care-engaged White patients were typically at higher risk
of death compared to African American or patients in
other racial groups, and also at higher risk of continued
disengagement once disengaged from care. However, the
mortality results should be interpreted as exploratory
because the CIs for those estimates were generally wide
with upper 95% CIs close to 1 even within this large
cohort.
Some of our findings reinforce existing evidence. For
example, age and sex-HIV risk factor effects on retention
in care reported here were consistent with existing
evidence [32]; our findings therefore support the current
recommendations that stress the needs of efforts to
improve retention among younger patients and among
male heterosexual PLWH. Regardless of sex and sexual
orientation, people who inject drugs have increased risk
of falling out of care including death.
There are several possible explanations for the differences
in our findings compared to previous studies. In addition
to cohort eligibility criteria and duration of follow-up,
the differences might be partly attributable to our
different time metric (200-day window) to capture
engagement and retention in care. It is less strict than the
usual definition of retention in care requiring at least 2–3
visits in a year [25]. Although there is no standard metric
to define retention in HIV medical care [33–35], the
200-day window (6 months þ 2 weeks) used here is a
good representation of the retention indicator recom-
mended by the US Department of Health Human
Services and the Institute of Medicine [36,37]. Also,
note that our findings are based on analysis of multiple
concurrent outcomes such as engagement, disengage-
ment, and death, whereas other analyses typically focused
on single outcomes. Therefore, our analysis captures
more comprehensive behaviors – the cyclic processes of
engagement and retention in care – beyond simple
retention, while accurately reflecting the current patient
monitoring plans in the CNICS cohort. However, as we
defined care visits based on viral load measures, it is
possible that some laboratory visits were misclassified
as clinical visits with a doctor, leading to potentially
overestimating retention in this study.
Our analysis was limited in that we did not control for
some important patient-level characteristics such as
substance abuse, depression, and insurance status, due
to the quality of the available data. Kozak et al. [38]
demonstrated utility of PRO over electronic health
records to determine substance abuse or depression status.
However, CNICS included standardized (across sites)
PRO measurements starting in 2000. The effect of
insurance was not examined because individuals had
multiple different insurance start dates without corre-
sponding stop dates. Due to limited sample size and
information, our analysis was not able to examine some
small-scale minor groups that deserve more close
attention such as transgender patients. Some demo-
graphic characteristics such as sex and race may be subject
to misclassification due to variable data collection
methods. Another limitation is that transferring to other
clinics outside of the CNICS network is not captured in
the CNICS database, which might result in inflation of
some transition rates associated with disengagement.
Finally, it should be noted that there are also barriers to
using EMR such as inaccuracies in transcription,
misclassification of some patient information, lack of
standard terminology and practice to enter data across
doctors, clinics, and/or sites.
In conclusion, our findings highlight the importance of
modeling longitudinal patterns of engagement and
retention in care to inform evidence-based approaches
to improve care retention tailored to specific patient
populations. Our approach may be used to develop
prediction algorithms for identifying individuals who
may be at higher risk of disengagement, loss, or death in
other clinical cohorts or in national surveillance data.
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